Checkmate Pharmaceuticals, Inc.
Annual report (10-K)
Latest 10-K/A filed Apr 29, 2022. Sentiment + YoY language diff vs prior year. Read sections →
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Top insiders
Most active reporters at Checkmate Pharmaceuticals, Inc.
| Name | Roles | Filings |
|---|---|---|
| Adelman Robert J | 10% Owner | 7 |
| Goodman Corey S | 10% Owner | 7 |
| Venbio Global Strategic Fund II L.P. | 10% Owner | 7 |
| Venbio Global Strategic Gp II, L.P. | 10% Owner | 7 |
| Venbio Global Strategic Gp II, Ltd. | 10% Owner | 7 |
Showing 1-5 of 16
All filings
23 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|